-
1 week ago | 
forbes.com | Eva Epker
When she was just 34 years old, Sue Paxman was diagnosed with breast cancer. As she started treatment, she experienced a side effect that 65% of chemotherapy patients face: chemotherapy-induced alopecia (CIA) or hair loss. “The most common theme we hear from people…is that it is ‘not just hair’. It goes so much deeper than that, and it is not vanity!” said Richard Paxman, CEO of Paxman Scalp Cooling.
-
3 weeks ago | 
forbes.com | Eva Epker
“Net worth”, “husband”, and “LinkedIn”: a recent study found that these three terms were the most common Google searches regarding female CEOs. In fact, queries about a female CEO’s spouse and family were 216% and 130% more common, respectively, than those same queries for a male CEO. In contrast, searches for a male CEO’s salary and education were 169% and 61% more common, respectively, than those same searchers for a female CEO.
-
1 month ago | 
forbes.com | Eva Epker
In 1894, a statue of Dr. James Marion Sim was erected in New York’s Bryant Park. It aimed to recognize the figure known as the “Father of Modern Gynecology” - but it didn’t consider the methods he used and the Black women he exploited in order to make those very same contributions. Dr. Sims experimented on up to 12 enslaved Black women: Lucy, Betsey, Anarcha, and nine others whose names remain unknown.
-
1 month ago | 
forbesargentina.com | Eva Epker
"Cuando me mudé a Estados Unidos, jamás cuestioné a mis médicos. Creía que el sistema de salud estadounidense era el mejor del mundo, así que si me recetaban algo, lo tomaba", contó Mila Magnani. El resultado fue una cantidad de pastillas que tomó durante toda su adolescencia: antibióticos para el acné, antidepresivos para regular el ánimo, anticonceptivos para el ciclo y espironolactona para el vello facial.
-
1 month ago | 
forbes.com | Eva Epker
“When I moved to the U.S., I never questioned my doctors. I believed the American healthcare system was the best in the world—so if something was prescribed, I took it,” explained Mila Magnani. The result was a flurry of pills that she took throughout her teen years: antibiotics for acne, antidepressants for mood regulation, birth control for her cycle, and spironolactone for facial hair.
-
Mar 8, 2025 | 
forbes.com | Eva Epker
What do CEO Lauren Makler, entrepreneur and Olympic athlete Alysia Montaño, and tennis great Maria Sharapova all have in common? Through the recent Level the Playing Field campaign, each one of them is helping to fill the gaps that female athletes face when planning and building their families. Launched this year on National Girls and Women in Sports Day on February 5,Level the Playing Field focuses on the need for fertility freedom for women in sports.
-
Feb 19, 2025 | 
forbes.com | Eva Epker
How much do clinical trials cost? The most-quoted are arguably that each trial individually costs a median of $19M, each trial for an eventually-approved drug costs a median of about $48M, and the estimated cost per participant was $41,413. But cost estimates vary. Recently, a 2023 paper estimated the overall cost range between $48 million and $225 million, a 2024 found the average cost to be about $117.4 million, and a 2025 paper cited the average cost to be between $30M and $50M.
-
Feb 19, 2025 | 
asianamericans.einnews.com | Eva Epker
How much do clinical trials cost? The most-quoted are arguably that each trial individually costs a median of $19M, each trial for an eventually-approved drug costs a median of about $48M, and the estimated cost per participant was $41,413. But cost estimates vary. Recently, a 2023 paper estimated the overall cost range between $48 million and $225 million, a 2024 found the average cost to be about $117.4 million, and a 2025 paper cited the average cost to be between $30M and $50M.
-
Feb 4, 2025 | 
forbes.com | Eva Epker
A Pap Smear every three years. A mammogram at least every other year. A physical every year. Guidelines from the United States Preventive Services Task Force (USPSTF) and the American College of Obstetricians and Gynecologists recommend that women have regular – and, usually, annual – health appointments, such as pap smears, mammogram, and physicals.
-
Jan 27, 2025 | 
forbes.com | Eva Epker
“In conclusion, our proof-of-concept study supports the potential of ulipristal in a combined regimen with misoprostol for safe and effective medication abortion.” So wrote a team of researchers in a study titled “A Proof-of-Concept Study of Ulipristal Acetate for Early Medication Abortion” published just last week: on January 23, 2025. Put another way, their results were that they had identified a possible alternative to the current medication abortion regime.
